Arthur S. Przybyl
2016
In 2016, Arthur S. Przybyl earned a total compensation of $2.5M as President, Chief Executive Officer and Director at ANI Pharmaceuticals, a 15% decrease compared to previous year.
Compensation breakdown
| Bonus | $57,200 |
|---|---|
| Non-Equity Incentive Plan | $343,200 |
| Option Awards | $751,500 |
| Salary | $572,000 |
| Stock Awards | $761,063 |
| Other | $29,100 |
| Total | $2,514,063 |
Przybyl received $761.1K in stock awards, accounting for 30% of the total pay in 2016.
Przybyl also received $57.2K in bonus, $343.2K in non-equity incentive plan, $751.5K in option awards, $572K in salary and $29.1K in other compensation.
Rankings
In 2016, Arthur S. Przybyl's compensation ranked 3,911th out of 14,075 executives tracked by ExecPay. In other words, Przybyl earned more than 72.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,911 out of 14,075 | 72nd |
Division Manufacturing | 1,366 out of 5,489 | 75th |
Major group Chemicals And Allied Products | 419 out of 1,895 | 78th |
Industry group Drugs | 305 out of 1,538 | 80th |
Industry Pharmaceutical Preparations | 240 out of 1,176 | 80th |
Source: SEC filing on April 6, 2017.
Przybyl's colleagues
We found four more compensation records of executives who worked with Arthur S. Przybyl at ANI Pharmaceuticals in 2016.
2016
Charlotte Arnold
ANI Pharmaceuticals
Chief Financial Officer
2016
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
2016
Robert Schrepfer
ANI Pharmaceuticals
Senior Vice President, New Business Development and Specialty Sales
2016
James Marken
ANI Pharmaceuticals